7,477
Views
7
CrossRef citations to date
0
Altmetric
Pain Medicine

From the pharmaceutical to the clinical: the case for effervescent paracetamol in pain management. A narrative review

, &
Pages 1039-1048 | Received 09 Oct 2020, Accepted 09 Mar 2021, Published online: 05 Apr 2021

References

  • Di Girolamo G, Opezzo JA, Lopez MI, et al. Relative bioavailability of new formulation of paracetamol effervescent powder containing sodium bicarbonate versus paracetamol tablets: a comparative pharmacokinetic study in fed subjects. Exp Opin Pharmacother. 2007;8(15):2449–2457.
  • Tittarelli R, Pellegrini M, Scarpellini MG, et al. Hepatotoxicity of paracetamol and related fatalities. Eur Rev Med Pharmacol Sci. 2017;21(1 Suppl):95–101.
  • Hider-Mlynarz K, Cavalié P, Maison P. Trends in analgesic consumption in France over the last 10 years and comparison of patterns across Europe. Br J Clin Pharmacol. 2018;84(6):1324–1334.
  • Moore RA, Moore N. Paracetamol and pain: the kiloton problem. Eur J Hosp Pharm. 2016;23(4):187–188.
  • Jibril F, Sharaby S, Mohamed A, et al. Intravenous versus oral acetaminophen for pain: systematic review of current evidence to support clinical decision-making. Can J Hosp Pharm. 2015;68(3):238–247.
  • Hagen M, Alchin J. Nonprescription drugs recommended in guidelines for common pain conditions. Pain Manag. 2020;10(2):117–129.
  • Graham GG, Davies MJ, Day RO, et al. The modern pharmacology of paracetamol: therapeutic actions, mechanism of action, metabolism, toxicity and recent pharmacological findings. Inflammopharmacology. 2013;21(3):201–232.
  • Jozwiak-Bebenista M, Nowak JZ. Paracetamol: mechanism of action, applications and safety concern. Acta Pol Pharmaceut. 2014;71:11–23.
  • Schug SA, Goddard C. Recent advances in the pharmacological management of acute and chronic pain. Ann Palliat Med. 2014;3(4):263–275.
  • Sevilla-Tirado FJ, Gonzalez-Vallejo EB, Leary AC, et al. Bioavailability of two new formulations of paracetamol, compared with three marketed formulations, in healthy volunteers. Methods Find Exp Clin Pharmacol. 2003;25(7):531–535.
  • Ameer B, Divoll M, Abernethy DR, et al. Absolute and relative bioavailability of oral acetaminophen preparations. J Pharm Sci. 1983;72(8):955–958.
  • Forrest JA, Clements JA, Prescott LF. Clinical pharmacokinetics of paracetamol. Clin Pharmacokin. 1982;7:93–107.
  • Rawlins MD, Henderson DB, Hijab AR. Pharmacokinetics of paracetamol (acetaminophen) after intravenous and oral administration. Eur J Clin Pharmacol. 1977;11(4):283–286.
  • Singla NK, Parulan C, Samson R, et al. Plasma and cerebrospinal fluid pharmacokinetic parameters after single-dose administration of intravenous, oral, or rectal acetaminophen. Pain Pract. 2012;12(7):523–532.
  • Lee WM. Acetaminophen (APAP) hepatotoxicity-Isn't it time for APAP to go away? J Hepatol. 2017;67(6):1324–1331.
  • European Directorate for the Quality of Medicines & HealthCare. European Pharmacopoeia (Ph. Eur.), 10th Edition; 2019. Available from: https://www.edqm.eu/en/european-pharmacopoeia-ph-eur-10th-edition..
  • USP 43-NF 38 (United States Pharmacopeia-National Formulary): United States Pharmacopeial Convention; 2019. Available from: https://www.uspnf.com/.
  • Srinath KR, Chowdary CP, Palanisamy P, et al. Formulation and evaluation of effervescent tablets of paracetamol. Int J Pharmaceut Res Dev (IJPRD). 2011;3:76–104.
  • Fathi M, Kazemi S, Zahedi F, et al. Comparison of oral bioavailability of acetaminophen tablets, capsules and effervescent dosage forms in healthy volunteers. Curr Issues Pharmacy Med Sci. 2018;31(1):5–9.
  • Moes AJ. Gastroretentive dosage forms. Crit Rev Therap Drug Carrier Syst. 1993;10(2):143–195.
  • Kelly K, O'Mahony B, Lindsay B, et al. Comparison of the rates of disintegration, gastric emptying, and drug absorption following administration of a new and a conventional paracetamol formulation, using gamma scintigraphy. Pharmaceut Res. 2003;20(10):1668–1673.
  • Ipci K, Öktemer T, Birdane L, et al. Effervescent tablets: a safe and practical delivery system for drug administration. ENT Updates. 2016;6:46–50.
  • Shaw LR, Irwin WJ, Grattan TJ, et al. The effect of selected water-soluble excipients on the dissolution of paracetamol and Ibuprofen. Drug Dev Ind Pharm. 2005;31(6):515–525.
  • Rostami-Hodjegan A, Shiran MR, Tucker GT, et al. A new rapidly absorbed paracetamol tablet containing sodium bicarbonate. II. Dissolution studies and in vitro/in vivo correlation. Drug Dev Indust Pharm. 2002;28(5):533–543.
  • Hunt JN, Pathak JD. The osmotic effects of some simple molecules and ions on gastric emptying. J Physiol. 1960;154(2):254–269.
  • Heading RC, Nimmo J, Prescott LF, et al. The dependence of paracetamol absorption on the rate of gastric emptying. Br J Pharmacol. 1973;47(2):415–421.
  • Moller PL, Norholt SE, Ganry HE, et al. Time to onset of analgesia and analgesic efficacy of effervescent acetaminophen 1000 mg compared to tablet acetaminophen 1000 mg in postoperative dental pain: a single-dose, double-blind, randomized, placebo-controlled study. J Clin Pharmacol. 2000;40(4):370–378.
  • Paracetamol 500 mg Effervescent Tablets. Summary of Product Characteristics; 2020. [Cited 2020 Sept 1]. Available from: https://www.medicines.org.uk/emc/product/6064/smpc. Accessed 1 September 2020.
  • Grattan T, Hickman R, Darby-Dowman A, et al. A five way crossover human volunteer study to compare the pharmacokinetics of paracetamol following oral administration of two commercially available paracetamol tablets and three development tablets containing paracetamol in combination with sodium bicarbonate or calcium carbonate. Eur J Pharm Biopharm. 2000;49(3):225–259.
  • Eichman JD, Robinson JR. Mechanistic studies on effervescent-induced permeability enhancement. Pharmaceut Res. 1998;15(6):925–930.
  • Eichman JD, Yassin AEB, Robinson JR. The influence of in-vivo carbonation on GI physiological processes and drug permeability. Eur J Pharmaceut Biopharmaceut. 1997;44(1):33–38.
  • Patel SG, Siddaiah M. Formulation and evaluation of effervescent tablets: a review. J Drug Delivery Ther. 2018;8(6):296–303.
  • Rathnayake AD, Mannapperuma U, Thambawita D, et al. Determination of in-vitro equivalence of paracetamol tablets. Int J Multidisc Stud. 2014;1:1–7.
  • Amidon GL, Lennernas H, Shah VP, et al. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharmaceut Res. 1995;12(3):413–420.
  • Shah VP, Amidon GGL, Amidon H, et al. G.L. Amidon, H. Lennernas, V.P. Shah, and J.R. Crison. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability, Pharm Res 12, 413-420, 1995-backstory of BCS. Aaps J. 2014;16(5):894–898.
  • Prescott LF. Kinetics and metabolism of paracetamol and phenacetin. Br J Clin Pharmacol. 1980;10(Suppl(S2):291S–298S.
  • Rygnestad T, Zahlsen K, Samdal FA. Absorption of effervescent paracetamol tablets relative to ordinary paracetamol tablets in healthy volunteers. Eur J Clin Pharmacol. 2000;56(2):141–143.
  • Szałek E, Karbownik A, Murawa D, et al. The pharmacokinetics of the effervescent vs. conventional tramadol/paracetamol fixed-dose combination tablet in patients after total gastric resection. Pharmacol Rep. 2014;66(1):159–164.
  • Divoll M, Greenblatt DJ, Ameer B, et al. Effect of food on acetaminophen absorption in young and elderly subjects. J Clin Pharmacol. 1982;22(11-12):571–576.
  • Moore RA, Derry S, Wiffen PJ, et al. Effects of food on pharmacokinetics of immediate release oral formulations of aspirin, dipyrone, paracetamol and NSAIDs - a systematic review. Br J Clin Pharmacol. 2015;80(3):381–388.
  • Ibanez Y, Rodriguez JM, Lujan M, et al. A pharmacokinetic study investigating the rate of absorption of a 500 mg dose of a rapidly absorbed paracetamol tablet and a standard paracetamol tablet. Curr Med Res Opinion. 2006;22:1893–1897.
  • Rostami-Hodjegan A, Shiran MR, Ayesh R, et al. A new rapidly absorbed paracetamol tablet containing sodium bicarbonate. I. A four-way crossover study to compare the concentration-time profile of paracetamol from the new paracetamol/sodium bicarbonate tablet and a conventional paracetamol tablet in fed and fasted volunteers. Drug Dev Ind Pharm. 2002;28(5):523–531.
  • Ganry H, Insuasty JH, Schmidely N. Comparison of onset of analgesia of effervescent and non-effervescent paracetamol based on calculation of rates of pain reduction abstract. J Clin Pharmacol. 1996;36:855.
  • Mehlisch DR, Jasper RD, Brown P, et al. Comparative study of ibuprofen lysine and acetaminophen in patients with postoperative dental pain. Clin Ther. 1995;17(5):852–860.
  • Seymour RA, Kelly PJ, Hawkesford JE. The efficacy of ketoprofen and paracetamol (acetaminophen) in postoperative pain after third molar surgery. Br J Clin Pharmacol. 1996;41(6):581–585.
  • Varrassi G, Muller-Schwefe G, Pergolizzi J, et al. Pharmacological treatment of chronic pain - the need for CHANGE. Curr Med Res Opin. 2010;26(5):1231–1245.
  • Morthorst BR, Erlangsen A, Nordentoft M, et al. Availability of paracetamol sold over the counter in Europe: a descriptive cross-sectional international survey of pack size restriction. Basic Clin Pharmacol Toxicol. 2018;122(6):643–649.
  • Anderson BJ, Holford NH, Woollard GA, et al. Perioperative pharmacodynamics of acetaminophen analgesia in children. Anesthesiology. 1999;90(2):411–421.
  • Gibb IA, Anderson BJ. Paracetamol (acetaminophen) pharmacodynamics: interpreting the plasma concentration. Arch Dis Child. 2008;93(3):241–247.
  • Mian P, van Esdonk MJ, Olkkola KT, et al. Population pharmacokinetic modelling of intravenous paracetamol in fit older people displays extensive unexplained variability. Br J Clin Pharmacol. 2019;85(1):126–135.
  • Moore RA, Derry S, Straube S, et al. Faster, higher, stronger? Evidence for formulation and efficacy for ibuprofen in acute pain. Pain. 2014;155(1):14–21.
  • Moore RA, Derry S, Straube S, et al. Validating speed of onset as a key component of good analgesic response in acute pain. Eur J Pain. 2015;19(2):187–192.
  • Laska EM, Siegel C, Sunshine A. Onset and duration: measurement and analysis. Clin Pharmacol Ther. 1991;49(1):1–5.
  • Verschuren F, Thys F, Wittebole X, et al. Effervescent paracetamol poisoning: a case report. Eur J Emerg Med. 2002;9(4):339–341.
  • Garnier R, Riboulet-Delmas G, Efthymiou ML. [Acute paracetamol poisoning. A retrospective study of data from the Paris Antipoison Center. 1974-1981]. Sem Hop Ther. 1982;58:435–439.
  • George J, Majeed W, Mackenzie IS, et al. Association between cardiovascular events and sodium-containing effervescent, dispersible, and soluble drugs: nested case-control study. BMJ. 2013;347:f6954.
  • Global status report on noncommunicable diseases 2014. Geneva: World Health Organization; 2014.
  • Perrin G, Korb-Savoldelli V, Karras A, et al. Cardiovascular risk associated with high sodium-containing drugs: a systematic review. PLoS One. 2017;12(7):e0180634.
  • Benitez-Camps M, Vinyoles-Bargallo E, Rebagliato-Nadal O, et al. Evaluation of the relationship between effervescent paracetamol and blood pressure: clinical trial. BMC Cardiovasc Dis. 2015;15:167.
  • Ubeda A, Llopico J, Sanchez MT. Blood pressure reduction in hypertensive patients after withdrawal of effervescent medication. Pharmacoepidem Drug Safe. 2009;18(5):417–419.
  • Wei L, Mackenzie IS, MacDonald TM, et al. Cardiovascular risk associated with sodium-containing medicines. Expert Opin Drug Saf. 2014;13(11):1515–1523.
  • Benitez-Camps M, Morros Padros R, Pera-Pujadas H, in representation of Paracetamol Investigators, et al. Effect of effervescent paracetamol on blood pressure: a crossover randomized clinical trial. J Hypertens. 2018;36(8):1656–1662.
  • Perrin G, Berdot S, Thomas F, et al. Evaluation of exposure to effervescent drugs in a large health check-up population in France: a cross-sectional study. BMJ Open. 2018;8(7):e022368.
  • Siau K, Khanna A. Hypernatremia secondary to soluble paracetamol use in an elderly man: a case report. Cases J. 2009;2:6707.
  • Kurtz TW, Morris RC. Jr. Dietary chloride and bicarbonate as determinants of desoxycorticosterone hypertension. J Hyperten. 1984;2:S371–S373.
  • Luft FC, Steinberg H, Ganten U, et al. Effect of sodium chloride and sodium bicarbonate on blood pressure in stroke-prone spontaneously hypertensive rats. Clin Sci (Lond)). 1988;74(6):577–585.
  • Zicha J, Kunes J. Haemodynamic changes induced by short- and long-term sodium chloride or sodium bicarbonate intake in deoxycorticosterone-treated rats. Acta Physiol Scand. 1994;151(2):217–223.
  • Luft FC, Zemel MB, Sowers JA, et al. Sodium bicarbonate and sodium chloride: effects on blood pressure and electrolyte homeostasis in normal and hypertensive man. J Hypertens. 1990;8(7):663–670.
  • Ganry O, Boudet J, Wargon C, et al. Effect of sodium bicarbonate and sodium chloride on arterial blood pressure, plasma renin activity and urinary prostaglandins in healthy volunteers. J Hypertens (Suppl). 1993;11:S202–S203.
  • Schorr U, Distler A, Sharma AM. Effect of sodium chloride- and sodium bicarbonate-rich mineral water on blood pressure and metabolic parameters in elderly normotensive individuals: a randomized double-blind crossover trial. J Hypertens. 1996;14:131–135.
  • Burnett I, Schachtel B, Sanner K, et al. Onset of analgesia of a paracetamol tablet containing sodium bicarbonate: A double-blind, placebo-controlled study in adult patients with acute sore throat. Clin Ther. 2006;28(9):1273–1278.
  • Schachtel BP, Meskin NA, Sanner KM. How 'fast' is over-the-counter (OTC) pain relief? [abstract. Clin Pharmacol Ther. 2005;77(2):P52–P52.
  • Ameen VZ, Pobiner BF, Giguere GC, et al. Ranitidine (Zantac) syrup versus Ranitidine effervescent tablets (Zantac) EFFERdose) in children: a single-center taste preference study. Paediatr Drugs. 2006;8(4):265–270.
  • Liu F, Ghaffur A, Bains J, et al. Acceptability of oral solid medicines in older adults with and without dysphagia: A nested pilot validation questionnaire based observational study. Int J Pharm. 2016;512(2):374–381.
  • Trippella G, Ciarcia M, de Martino M, et al. Prescribing controversies: an updated review and meta-analysis on combined/alternating use of ibuprofen and paracetamol in febrile children. Front Pediatr. 2019;7:217.
  • Miehlke S, Hruz P, Vieth M, et al. A randomised, double-blind trial comparing budesonide formulations and dosages for short-term treatment of eosinophilic oesophagitis. Gut. 2016;65(3):390–399.